Expression of the oncofetal IGF2BP1 is upregulated in MNA neuroblastoma (13, 14), promotes MYCN protein and RNA expression (13), and is considered a potent and conserved inhibitor of miRNA-dependent downregulation of oncogenic factors in cancer (15, 16). The gene discussed is MYCN; the disease is neuroblastoma.